Composition
- Active ingredients
- THEOPHYLLINE 125MG
Strengths and forms
The FDA lists each strength of a product separately; these pages share one label.
- THEOPHYLLINE 300MG · Capsule, extended releaseANDA087894-001 · Discontinued
- THEOPHYLLINE 200MG · Capsule, extended releaseANDA087893-001 · Discontinued
- THEOPHYLLINE 100MG · Capsule, extended releaseANDA087892-001 · Discontinued
- THEOPHYLLINE 75MG · Capsule, extended releaseANDA089539-001 · Discontinued
- THEOPHYLLINE 125MG · Capsule, extended releaseThis page
- THEOPHYLLINE 50MG · Capsule, extended releaseANDA088269-001 · Discontinued
Official product information
Drugs@FDA lists the approved labels, letters and reviews for application ANDA089540.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Brand name
- Slo-Bid
- Active substance
- theophylline
- Route
- Oral
- Dosage form
- Capsule, extended release
- Applicant
- Sanofi Aventis US
- Status
- Discontinued
- FDA approval
- 10 May 1989
- Application
- ANDA089540-001